SEVERE WX : Wind Advisory View Alerts

US FDA announces emergency authorization for convalescent plasma to treat Covid-19

The US Food and Drug Administration on Sunday issued an emergency use authorization for convalescent plasma to treat Covid-19, saying the "known and potentia...

Posted: Aug 24, 2020 7:18 AM

The US Food and Drug Administration on Sunday issued an emergency use authorization for convalescent plasma to treat Covid-19, saying the "known and potential benefits of the product outweigh the known and potential risks of the product."

The FDA said more than 70,000 patients had been treated with convalescent plasma,which is made using the blood of people who have recovered from coronavirus infections.

"Today I am pleased to make a truly historic announcement in our battle against the China virus that will save countless lives," President Trump said at a White House briefing, referring to the coronavirus that causes Covid-19. "Today's action will dramatically increase access to this treatment."

Last week, Trump accused some health officials of playing politics regarding an EUA for convalescent plasma. When asked about the FDA not having granted an EUA, Trump said the reason was political.

On Sunday, a source who is close to the White House Coronavirus Task Force told CNN the FDA had reviewed additional data to inform its EUA decision. This official has not personally reviewed the data. They added the FDA is under no obligation to consult anyone outside the agency about its decision.

Convalescent plasma is taken from the blood of people who have recovered from Covid-19. At the end of March, the FDA set up a pathway for scientists to try convalescent plasma with patients and study its impact. It has already been used to treat more than 60,000 Covid-19 patients.

However, like blood, convalescent plasma is in limited supply and must come from donors. And while there are promising signals from some studies, there is not yet randomized clinical trial data on convalescent plasma to treat Covid-19. Some of those trials are underway.

Experts say more data is needed

US Health and Human Services Secretary Alex Azar said studies involving 70,000 volunteers justified the EUA.

"The data we gathered suggests that patients who were treated early in their disease course, within three days of being diagnosed, with plasma containing high levels of antibodies, benefited the most from treatment. We saw about a 35% better survival in the patients who benefited most from the treatment," Azar told the White House briefing.

"We dream in drug development of something like a 35% mortality reduction. This is a major advance in the treatment of patients. A major advance."

Azar appeared to be referring to a national study of 35,000 patients treated with convalescent plasma. The study, released August 12 in a pre-print, meaning it had not yet been peer-reviewed, showed that 8.7% of patients who were treated within three days of diagnosis died, compared to about 12% of patients who were treated four days or more after their diagnosis. That's about a difference of about 37%.

Those treated with plasma containing the highest levels of antibodies had a 35% lower risk of dying within a week compared to those treated with less-rich plasma.

But this is not how doctors usually measure the benefit of a treatment. The gold standard is a randomized, placebo-controlled clinical trial that means that doctors randomly choose who gets the treatment and who doesn't, so they can truly tell whether it's the treatment affecting survival and not something else. And the comparison is usually treated patients compared to untreated patients -- not patients treated earlier compared to those treated later.

"The problem is, we don't really have enough data to really understand how effective convalescent plasma is," Dr. Jonathan Reiner, a professor of medicine at George Washington University and a CNN medical analyst, said Sunday.

"While the data to date show some positive signals that convalescent plasma can be helpful in treating individuals with COVID-19, especially if given early in the trajectory of disease, we lack the randomized controlled trial data we need to better understand its utility in COVID-19 treatment," Dr. Thomas File, president of the Infectious Diseases Society of America, said in a statement.

Dr. Paul Offit, director of the Vaccine Education Center at Children's Hospital of Philadelphia, said he thought it likely the White House pressured the FDA into pushing through the EUA.

"I think what's happening here is you're seeing bullying, at least at the highest level of the FDA, and I'm sure that there are people at the FDA right now who are the workers there that are as upset about this as I am," Offit told CNN's Wolf Blitzer.

According to a knowledgeable source, Dr. Francis Collins, head of the National Institutes of Health; Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases and Dr. H. Clifford Lane, who works under Fauci at NIAID, were among government health officials who had previously been skeptical there was enough data to justify emergency authorization of plasma for Covid-19.

'Great demand from patients and doctors'

President Trump said there might have been a holdup on the EUA, "but we broke the logjam over the last week to be honest," Trump said at the briefing. He said he believed there were officials at the FDA and in the Department of Health and Human Services "that can see things being held up and wouldn't mind so much."

"It's my opinion, very strong opinion, and that's for political reasons," Trump said.

Hahn denied the decision was made for any other than legitimate medical reasons.

"I took an oath as a doctor 35 years ago to do no harm. I abide by that every day," Hahn said in a statement to CNN's Jim Acosta.

"I've never been asked to make any decision at the FDA based on politics. The decisions the scientists at the FDA are making are done on data only."

Hahn said during the briefing the agency decided the treatment was safe, and looked potentially effective enough to justify the EUA, which is not the same as full approval.

"So we have ongoing clinical trials that are randomized between a placebo, or an inactive substance, and the convalescent plasma. While that was going on we knew there was great demand from patients and doctors," Hahn said.

While an EUA can open the treatment to more patients, it could also have the effect of limiting enrollment in clinical trials that determine whether it's effective.

On Thursday, Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, said that doctors have treated so many Covid-19 patients with convalescent plasma, it has been difficult to figure out if the treatment works.

"The problem with convalescent plasma is the great enthusiasm about it," Woodcock said in an online conversation about the latest science behind monoclonal antibody treatments and convalescent plasma. "It exceeded anyone's expectation as far as the demand."

Bioethics expert Art Caplan said he's worried about whether there's a large enough supply of convalescent plasma. With an EUA, doctors will be more likely to give convalescent plasma without tracking data, so it will then be difficult to determine which donors have the most effective plasma, and which patients are the best candidates to receive it.

"We're going to get a gold rush towards plasma, with patients demanding it and doctors demanding it for their patients," said Caplan, the founding head of the Division of Medical Ethics at NYU School of Medicine.

Huntsville
Clear
60° wxIcon
Hi: 80° Lo: 53°
Feels Like: 60°
Florence
Partly Cloudy
66° wxIcon
Hi: 79° Lo: 54°
Feels Like: 66°
Fayetteville
Clear
63° wxIcon
Hi: 78° Lo: 51°
Feels Like: 63°
Decatur
Clear
61° wxIcon
Hi: 80° Lo: 55°
Feels Like: 61°
Scottsboro
Partly Cloudy
49° wxIcon
Hi: 81° Lo: 52°
Feels Like: 49°
WAAY Radar
WAAY WAAY-TV Cam
WAAY Temperatures

Alabama Coronavirus Cases

Cases: 530744

Reported Deaths: 10978
CountyCasesDeaths
Jefferson764931522
Mobile40959804
Madison34735503
Tuscaloosa25749452
Montgomery24327589
Shelby23425249
Baldwin21123308
Lee15873171
Calhoun14496314
Morgan14288279
Etowah13826353
Marshall12213223
Houston10561281
Elmore10052205
Limestone9958151
Cullman9659193
St. Clair9652243
Lauderdale9420241
DeKalb8828186
Talladega8220176
Walker7231277
Autauga6918108
Jackson6809112
Blount6656137
Colbert6296134
Coffee5509119
Dale4830111
Russell440738
Chilton4284112
Franklin425682
Covington4118118
Tallapoosa4026152
Escambia393376
Chambers3560123
Dallas3547151
Clarke351061
Marion3116101
Pike310877
Lawrence300298
Winston274272
Bibb260564
Marengo249664
Geneva249477
Pickens234361
Barbour230757
Hale222877
Butler215969
Fayette212262
Henry188744
Cherokee184645
Randolph180141
Monroe177340
Washington167239
Macon158950
Clay156156
Crenshaw152257
Cleburne148941
Lamar142535
Lowndes138753
Wilcox127030
Bullock123041
Conecuh110329
Perry107526
Coosa107228
Sumter104432
Greene92334
Choctaw60624
Out of AL00
Unassigned00

Tennessee Coronavirus Cases

Cases: 852841

Reported Deaths: 12255
CountyCasesDeaths
Shelby956561619
Davidson89355933
Knox50675635
Hamilton44280494
Rutherford43046434
Williamson28015217
Sumner24012349
Montgomery20255225
Wilson18804234
Out of TN1840797
Unassigned16998134
Sullivan16794294
Blount15490193
Bradley15032150
Washington14597245
Maury13499172
Sevier13391175
Putnam11396175
Madison11168242
Robertson9756131
Anderson8760172
Hamblen8610173
Greene7877155
Tipton7359103
Coffee6905121
Dickson6840110
Cumberland6734132
Carter6634158
Gibson6526146
McMinn650898
Bedford6506128
Roane6282105
Jefferson6211124
Loudon613069
Hawkins6077107
Lawrence593887
Monroe584095
Warren554881
Dyer5425106
Franklin515090
Fayette506877
Cheatham455355
Obion454196
Cocke450099
Lincoln435763
Rhea434875
Marshall419058
Campbell415463
Weakley412865
Giles3996100
Henderson378976
White364170
Macon361978
Carroll361683
Hardin357167
Hardeman352664
Lauderdale318944
Henry318576
Claiborne318273
Marion312347
Scott312345
Overton301161
Wayne296334
Hickman284046
McNairy282054
DeKalb279654
Smith277839
Haywood271162
Grainger262850
Morgan250139
Trousdale250122
Fentress241547
Johnson240739
Chester214351
Bledsoe214211
Polk207824
Unicoi203549
Crockett203248
Cannon192031
Union190734
Humphreys179927
Grundy179334
Lake170326
Sequatchie169829
Benton166540
Decatur158639
Lewis158126
Meigs139125
Stewart132528
Jackson132036
Clay110131
Houston109333
Perry106628
Moore101117
Van Buren84723
Pickett76024
Hancock58912

Community Events